ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharma collaboration science funding

Pharma Looks to Outer Space to Boost Drug R&D
Katarina Zimmer | Dec 1, 2020 | 9 min read
There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen.
Pharma gets friendly
Edyta Zielinska | Jul 20, 2008 | 2 min read
The biggest drug makers are known for cut-throat competition, not collaboration. But last week Pfizer, Merck and Eli Lilly bucked that trend, announcing the creation of a joint company called Enlight BioSciences to help fund and develop enabling technologies to speed drug development. The company, formed with the help of PureTech Ventures, a venture capital firm in Boston, will seek out and fund linkurl:inventions from academic institutions;http://www.the-scientist.com/article/display/54666/ aro
Best Places to Work Academia, 2011
The Scientist | Jul 1, 2011 | 9 min read
Whether it’s attending a Scottish dance party or asking physics buffs to custom build your tools, researchers at this year’s top institutions are getting creative at work.
Samantha Maragh speaks on stage after receiving the State of Maryland Outstanding Young Scientist Award 2019.
Making Standards Exceptional
Meenakshi Prabhune, PhD | Dec 4, 2023 | 9 min read
Samantha Maragh has taken on the difficult challenge of standardizing assays, data norms, and terminology in the ever evolving genome editing field.
Tag, You're It
Carina Storrs | Feb 1, 2014 | 7 min read
A guide to DNA-encoded libraries for drug discovery
Arctic, polar, polar research, animal movement, tracking, climate change, big data, global warming
Animal Movement Data Reveal Effects of Climate Change in Arctic
Amanda Heidt | Nov 5, 2020 | 5 min read
Environmental engineer Gil Bohrer discusses how long-term, large-scale tracking data can shed light on the unexpected ways animals are responding to changes in the Arctic.
Activities Discovered for Some Inactive Drug Ingredients
Ruth Williams | Jul 23, 2020 | 4 min read
Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.
US Selects Two COVID-19 Vaccine Candidates for Huge Investments
Amy Schleunes | Apr 1, 2020 | 2 min read
The government is assisting Johnson & Johnson and Moderna with expediting clinical testing while at the same time prepping for large-scale manufacturing.
Dodging Patent Perils in Collaborations
Phillip Jones | Nov 7, 2004 | 6 min read
Research collaborations often form the bedrock of truly great science. Scientific alliances can also help businesses commercialize their basic research or reveal the next blockbuster drug. In recent years, economic and competitive pressures have encouraged research collaborations between universities and industry, and between small biotech companies and Big Pharma. While these associations frequently prove to be beneficial for all parties, research collaborations can sometimes trap the unwary, c

Run a Search

ADVERTISEMENT